Joanne Wuensch
Stock Analyst at Citigroup
(4.05)
# 419
Out of 5,182 analysts
470
Total ratings
58.44%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Buy | $117 → $110 | $83.32 | +32.02% | 23 | Apr 7, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $94 → $87 | $62.07 | +40.16% | 38 | Apr 7, 2026 | |
| SYK Stryker | Maintains: Buy | $420 → $385 | $327.51 | +17.55% | 16 | Apr 7, 2026 | |
| PODD Insulet | Downgrades: Neutral | $338 → $230 | $189.56 | +21.33% | 19 | Apr 7, 2026 | |
| MMED MiniMed Group | Initiates: Buy | $23 | $13.20 | +74.24% | 1 | Mar 31, 2026 | |
| JNJ Johnson & Johnson | Maintains: Buy | $250 → $274 | $227.50 | +20.44% | 18 | Mar 11, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $242 → $214 | $122.35 | +74.91% | 23 | Mar 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $11 → $9 | $10.57 | -14.85% | 17 | Mar 11, 2026 | |
| HAE Haemonetics | Maintains: Neutral | $75 → $70 | $59.93 | +16.80% | 12 | Mar 11, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $88 → $84 | $68.83 | +22.04% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $81 → $74 | $66.28 | +11.65% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $77 → $84 | $61.57 | +36.43% | 18 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $18.16 | +4.63% | 23 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $136 | $91.13 | +49.24% | 24 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $590 | $482.22 | +22.35% | 20 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.1 → $6.5 | $4.34 | +49.77% | 15 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $88 → $87 | $64.42 | +35.05% | 23 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $92 | $86.02 | +6.95% | 10 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $15.82 | +32.74% | 7 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $98 | $91.26 | +7.39% | 24 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $350 → $374 | $329.89 | +13.37% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $125 | $121.48 | +2.90% | 23 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $84.15 | +20.02% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $20.36 | +8.06% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.27 | +226.77% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $152.14 | +64.32% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $75.80 | -8.97% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $219.85 | -42.23% | 6 | Dec 10, 2018 |
Medtronic
Apr 7, 2026
Maintains: Buy
Price Target: $117 → $110
Current: $83.32
Upside: +32.02%
Boston Scientific
Apr 7, 2026
Maintains: Buy
Price Target: $94 → $87
Current: $62.07
Upside: +40.16%
Stryker
Apr 7, 2026
Maintains: Buy
Price Target: $420 → $385
Current: $327.51
Upside: +17.55%
Insulet
Apr 7, 2026
Downgrades: Neutral
Price Target: $338 → $230
Current: $189.56
Upside: +21.33%
MiniMed Group
Mar 31, 2026
Initiates: Buy
Price Target: $23
Current: $13.20
Upside: +74.24%
Johnson & Johnson
Mar 11, 2026
Maintains: Buy
Price Target: $250 → $274
Current: $227.50
Upside: +20.44%
iRhythm Holdings
Mar 11, 2026
Maintains: Buy
Price Target: $242 → $214
Current: $122.35
Upside: +74.91%
Integra LifeSciences Holdings
Mar 11, 2026
Maintains: Sell
Price Target: $11 → $9
Current: $10.57
Upside: -14.85%
Haemonetics
Mar 11, 2026
Maintains: Neutral
Price Target: $75 → $70
Current: $59.93
Upside: +16.80%
GE HealthCare Technologies
Mar 11, 2026
Maintains: Neutral
Price Target: $88 → $84
Current: $68.83
Upside: +22.04%
Mar 11, 2026
Maintains: Neutral
Price Target: $81 → $74
Current: $66.28
Upside: +11.65%
Mar 11, 2026
Maintains: Buy
Price Target: $77 → $84
Current: $61.57
Upside: +36.43%
Mar 11, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $18.16
Upside: +4.63%
Mar 11, 2026
Maintains: Buy
Price Target: $140 → $136
Current: $91.13
Upside: +49.24%
Mar 11, 2026
Upgrades: Buy
Price Target: $590
Current: $482.22
Upside: +22.35%
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $4.34
Upside: +49.77%
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $64.42
Upside: +35.05%
Feb 20, 2026
Maintains: Neutral
Price Target: $75 → $92
Current: $86.02
Upside: +6.95%
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $15.82
Upside: +32.74%
Feb 11, 2026
Maintains: Neutral
Price Target: $94 → $98
Current: $91.26
Upside: +7.39%
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $329.89
Upside: +13.37%
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $121.48
Upside: +2.90%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $84.15
Upside: +20.02%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $20.36
Upside: +8.06%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.27
Upside: +226.77%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $152.14
Upside: +64.32%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $75.80
Upside: -8.97%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $219.85
Upside: -42.23%